マンジブラー・リポジショニング: TMD の治療のための新しいアプローチ
Diwakar Singh1, Alain Landry2, Martina Schmid-Schwap3
1Center for Clinical Research, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria.
Bioengineering (Basel, Switzerland)
|August 28, 2025
まとめ
コントロールされた下再定位 (CMR) 方法は,前再定位用の理想的な治療位置を正確に決定します. このテクニックは,縮小 (DDwR) による椎椎間板変位を効果的に治療し,椎間板の位置を変え,痛みを軽減します.
科学分野:
- 歯科
- 矯正歯科
- 生物医学工学
背景:
- テンポロマンディブル関節障害 (TMD),特に縮小性椎間板変位 (DDwR) は一般的であり,クリック,痛み,および制限されたの動きを引き起こします.
- 現在の前部再定位スプリント (ARS) は,解剖学的変化と標準化不足により,最適な治療位置 (Th.P) を達成する上で課題に直面しています.
研究 の 目的:
- ARSの個別化されたTh.Pを定義するための制御下再定位 (CMR) 方法の導入と評価.
- ディスクの位置変更と痛みの軽減を分析することによって,DDwRの治療におけるCMRの有効性を評価する.
主な方法:
- CMR方法は,臨床検査,MRI,コンピュータ化された頭脳測定,コンピュータ化されたコンディログラフィー,神経筋肉パルプーション,およびコンディラーポジションバリエーター (CPV) を統合しています.
- 治療には,特定された個別化されたTh.P.を用いて製造されたCMR安定剤 (スプリント) が使われた.
- 治療の結果は,フォローアップMRIとVAS (視覚アナログスケール) の痛みのスコアを使用して6ヶ月で評価されました.
主要な成果:
- 治療後のMRIは,37の関節のうち36の関節の再定位が成功したことを確認しました (97. 3%).
- 6ヶ月のフォローアップで痛みの有意な減少が観察されました.
- CMR法では,DDwRの関節脱が97.3%減少しました.
結論:
- CMR方法は,前部再定位スプリントのTh.Pを決定するための正確で個別化されたアプローチを提供します.
- この方法はDDwRの治療に効果があり,ディスクの位置変更と痛みの軽減につながります.
- 精密で個別化されたTh.Pの決定は,T.M.Dの効果的な前部再定位治療に不可欠です.
関連する概念動画
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...


